Results

Total Results: 222 records

Showing results for "sedation".

41. Management of Insomnia Disorder in Adults: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
    August 01, 2017 - people with primary depression �� Severe anaphylactic or anaphylactoid reactions �� Possible profound sedation

42. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
    June 15, 2010 - Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation … Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation … Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation … Treatment emergent symptoms as follows: Sexual dysfunction symptoms, Neuropsychiatric symptoms or sedation

43. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
    May 01, 2022 - There may be a large increased risk of dizziness and sedation, and a moderate increased risk of nausea … THC to CBD ratio) may be associated with moderate improvement in pain severity and increased risk of sedation … Sedation for comparable THC to CBD ratio versus placebo (short-term, 4 weeks to 6 months followup) … Sedation for high THC versus placebo (short-term, 4 weeks to 6 months followup) Abbreviations: CI … Placebo Sedation 3 RCTs (N=335)9- 11 Moderate Direct Consistent Imprecise Unknown Moderate effect

44. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis

45. Disposition of Comments Report for Acute Migraine Treatment in Emergency Settings (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_disposition-comments.pdf
    November 27, 2012 - Commentator & Affiliation Section Comment Response Peer Reviewer #4 Structured abstract "The risk of sedation … the following information from the abstract for both metoclopromide and neuroleptics: "The risk of sedation … The risk of sedation is from the side effects section under both agents, and the reference to the 10 … The most common side effects were skin and local reactions, sedation, digestive problems, nausea or … reestablish the homeostasis needed to abort an attack. no one has looked to low dose ketamine followed by sedation

46. Disposition of Comments Report for Comparative Effectiveness Review #68 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
    July 01, 2012 - Peer Reviewer 3 Introduction I recommend adding that NPPV does not require moderate sedation (instead … of only “deep” sedation) Page ES-2, line 26: add “moderate and/or” just prior to “…deep sedation” … Page 3, line 39: add “moderate and/or” just prior to “…deep sedation” The text has been modified to … specify “moderate and/or deep sedation.”

47. Ptsd-Adults-Trauma-Interventions Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adults-trauma-interventions_executive.pdf
    April 01, 2013 - In one RCT, dosing of sedation (light vs. deep) in critically ill patients did not affect posttraumatic … Robbery victims29 PTSD symptom severity Inconclusive, single trial (N=77) Insufficient Pharmacological sedation … trial (N=236), inconsistent findings at different assessment intervals Insufficient Pharmacological sedation … One randomized open-label trial considered comparative risk of harms from light versus deep sedation … Randomized trial of light versus deep sedation on mental health after critical illness.

48. Disposition of Comments CER 219 Antipsychotics for the Prevention and Treatment of Delirium (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/delirium-disposition-comments.pdf
    September 03, 2019 - review SPECIFICALLY involves antipsychotics for delirium, and NOT for other potential uses such as sedation … Public Reviewer #1 (Medicus, Jennifer [APA]) Results Page 29, sedation haloperidol v placebo – in … The absence of sedation with a given treatment is, in fact, important to know when assessing the potential … It is precisely because of the rare events in relation to sedation that we have been unable to come

49. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
    January 01, 2007 - In the CATIE trial, risperidone, quetiapine, and olanzapine were each more likely to cause sedation than … Odds were also higher for gastrointestinal problems, increased salivation, fatigue, EPS, and sedation … Compared to placebo, all atypicals were associated with sedation in multiple pooled analyses for all

50. Cannabis-2023-Surv-Rep-1-App-F (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis

51. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis

52. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - (Numerator) Intervention A, N Analyzed for Sedation (Denominator) Intervention A, % With Sedation Intervention … B, N With Sedation (Numerator) Intervention B, N Analyzed for Sedation (Denominator) Intervention B … , % With Sedation Intervention C, N With Sedation (Numerator) Intervention C, N Analyzed for Sedation … (Denominator) Intervention C, % With Sedation Intervention D, N With Sedation (Numerator) Intervention … D, N Analyzed for Sedation (Denominator) Intervention D, % With Sedation Intervention A, N of Cannabis

53. Comparative Effectiveness of Strategies to De-escalate Aggressive Behavior in Psychiatric Patients in Acute Care Settings (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
    October 01, 2016 - psychiatrically ill, violently agitated patients requiring chemical restraint produced more rapid sedation … and greater sedation overall than intramuscular lorazepam68 (one RCT, insufficient SOE). … other medication protocols: Benefits (continued) Change in aggressive behavior (continued) Sedation … Another RCT reported on acute extrapyramidal events and incidence of marked sedation in a comparison … flunitrazepam at 90 minutes.48 Marked sedation 28 Insufficient Medium risk of bias, consistency

54. Crosscutting-Horizon-Scan-High-Impact-1506 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - Computer-assisted system (Sedasys) for propofol sedation during gastrointestinal endoscopy procedures …  Computer-assisted system (Sedasys) for propofol sedation during gastrointestinal endoscopy procedures … system intended to aid clinicians in delivering propofol for minimal to moderate sedation during routine … The Sedasys sedation system is intended to allow teams led by physicians who are not anesthesiologists … expressed views that the Sedasys system does not address a significant unmet need because alternative sedation

55. Amended Protocol: Interventions for Breathlessness in Patients with Advanced Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea-protocol-amended.pdf
    May 19, 2020 - rate • Blood pressure • Objective measure of exercise capacity, e.g., 6-minute walk test • Level of sedation … bicarbonate levels • Heart rate • Blood pressure • Objective measure of exercise capacity • Level of sedation

56. Cannabis-2023-Surv-Rep-4-Table-E-5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
    January 01, 2023 - C Sedation 3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

57. Cannabis-2022-Surv-Rep-4-Table-F5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-table-F5.xlsx
    January 01, 2022 - C Sedation 3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

58. Identification and Treatment of Post-Acute Coronary Syndrome (ACS) Depression: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-depression-research-protocol-amended.pdf
    February 15, 2017 - Other risks: akathisia, restlessness, sedation, headache, nausea and vomiting Olanzapine6 For bipolar … safety alert: DRESS (drug reaction with eosinophilia and systemic symptoms) FDA black box: delirium/sedation … syndrome with long acting injection (likely not relevant to use in depression) Other risks: akathisia, sedation … Quetiapine7 Yes, as an adjunct with an antidepressant Other risks: sedation, hypertension, cataracts … but not limited to constipation, urinary retention and blurred vision) and CNS depression including sedation

59. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
    March 14, 2012 - procedure, a manometry catheter is inserted into the pyloric channel with endoscopic guidance and sedation … motility capsule include that it is wireless and painless, can be used in an office setting without sedation … The catheter is left in place in some cases for up to 24 hours, and recordings are obtained after sedation … would capture the number of hours without anything by mouth before the procedure and the method of sedation

60. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
    December 01, 2010 - terms of extrapyramidal side effects and tardive dyskinesia, but produce other side effects, including sedation … General: extrapyramidal side effects, weight gain, agitation, constipation, sedation, elevated cholesterol … behaviors, death by suicide  General: extrapyramidal effects, weight gain, agitation, constipation, sedation … • General adverse events: extrapyramidal effects, weight gain, agitation, constipation, sedation,